Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow® RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting
April 26, 2024
Roivios announced today that it received FDA breakthrough device designation for its JuxtaFlow renal assist device (RAD).
